outcome phenotype
Evidence from:
primary |
all sources
Related entities (2)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| genetic variants | associated_with | outcome | — | 2 |
| SNP | risk_factor_for | outcome | — | 1 |
Mentioned in (67)
Papers in which this entity is mentioned.
- A guide to transcriptomic deconvolution in cancer. (2026)
- Whole-genome landscapes of 1,364 breast cancers. (2026)
- Child Ability and Parental Attributions: Development and Validation of the Reasons for Children's Behavior Scale. (2026)
- Chromosomal instability as a driver of cancer progression. (2025)
- Flexynesis: A deep learning toolkit for bulk multi-omics data integration for precision oncology and beyond. (2025)
- Parenting by individuals with fetal alcohol spectrum disorders and neurobehavioral outcomes in their offspring. (2024)
- Splicing neoantigen discovery with SNAF reveals shared targets for cancer immunotherapy. (2024)
- Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer. (2024)
- Insights for precision oncology from the integration of genomic and clinical data of 13,880 tumors from the 100,000 Genomes Cancer Programme. (2024)
- A Novel Tissue-Free Method to Estimate Tumor-Derived Cell-Free DNA Quantity Using Tumor Methylation Patterns. (2023)
- Desmoplastic stromal signatures predict patient outcomes in pancreatic ductal adenocarcinoma. (2023)
- Comprehensive repertoire of the chromosomal alteration and mutational signatures across 16 cancer types from 10,983 cancer patients (2023)
- Machine learning for genetics-based classification and treatment response prediction in cancer of unknown primary. (2023)
- Mapping clustered mutations in cancer reveals APOBEC3 mutagenesis of ecDNA. (2022)
- Explainable multiview framework for dissecting spatial relationships from highly multiplexed data. (2022)
- Single-cell analysis of hepatoblastoma identifies tumor signatures that predict chemotherapy susceptibility using patient-specific tumor spheroids. (2022)
- Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression. (2022)
- Feasibility of whole genome and transcriptome profiling in pediatric and young adult cancers. (2022)
- Circulating Tumor DNA as a Biomarker in Patients With Stage III and IV Wilms Tumor: Analysis From a Children's Oncology Group Trial, AREN0533. (2022)
- Circulating Tumor DNA Is Associated with Response and Survival in Patients with Advanced Leiomyosarcoma. (2022)
- Effects of Prenatal Alcohol Exposure on the Volumes of the Lateral and Medial Walls of the Intraparietal Sulcus. (2021)
- Multivariate analysis of 1.5 million people identifies genetic associations with traits related to self-regulation and addiction. (2021)
- Biologically informed deep neural network for prostate cancer discovery. (2021)
- Polygenic risk scores: from research tools to clinical instruments. (2020)
- Tutorial: a guide to performing polygenic risk score analyses. (2020)
- Extrachromosomal DNA is associated with oncogene amplification and poor outcome across multiple cancers. (2020)
- Diverse noncoding mutations contribute to deregulation of cis-regulatory landscape in pediatric cancers. (2020)
- Neoadjuvant checkpoint blockade for cancer immunotherapy. (2020)
- Comprehensive germline genomic profiles of children, adolescents and young adults with solid tumors. (2020)
- Single-Cell RNA-Seq Reveals AML Hierarchies Relevant to Disease Progression and Immunity. (2019)
- Exploring the relationship between polygenic risk for cannabis use, peer cannabis use and the longitudinal course of cannabis involvement. (2019)
- Comparative RNA-seq analysis aids in diagnosis of a rare pediatric tumor. (2019)
- Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study. (2019)
- Germline variants associated with leukocyte genes predict tumor recurrence in breast cancer patients. (2019)
- Genome-Informed Targeted Therapy for Osteosarcoma. (2019)
- Comprehensive analysis of structural variants in breast cancer genomes using single molecule sequencing (2019)
- CNVScope: Visually Exploring Copy Number Aberrations in Cancer Genomes. (2019)
- Identifying simultaneous rearrangements in cancer genomes. (2018)
- Detection of Somatic Structural Variants Enables Quantification and Characterization of Circulating Tumor DNA in Children With Solid Tumors. (2018)
- Genome doubling shapes the evolution and prognosis of advanced cancers. (2018)
- Personal Cancer Genome Reporter: variant interpretation report for precision oncology. (2018)
- The Immune Landscape of Cancer. (2018)
- Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group. (2018)
- Tumor fraction in cell-free DNA as a biomarker in prostate cancer. (2018)
- Copy number signatures and mutational processes in ovarian carcinoma. (2018)
- Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma. (2017)
- Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution. (2017)
- Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. (2017)
- Second-Trimester Ultrasound as a Tool for Early Detection of Fetal Alcohol Spectrum Disorders. (2016)
- The Influence of Extrinsic Reinforcement on Children with Heavy Prenatal Alcohol Exposure. (2016)
- FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing. (2016)
- Comprehensive analyses of tumor immunity: implications for cancer immunotherapy. (2016)
- Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. (2016)
- A Sleeping Beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasis. (2015)
- Comparison of RNA-seq and microarray-based models for clinical endpoint prediction. (2015)
- Inference of high resolution HLA types using genome-wide RNA or DNA sequencing reads. (2014)
- Dynamic analyses of alternative polyadenylation from RNA-seq reveal a 3'-UTR landscape across seven tumour types. (2014)
- Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations. (2014)
- Clonal evolution in hematological malignancies and therapeutic implications. (2014)
- The effects of prenatal alcohol exposure and attention-deficit/hyperactivity disorder on psychopathology and behavior. (2013)
- A comparative analysis of algorithms for somatic SNV detection in cancer. (2013)
- The genomic landscape of hypodiploid acute lymphoblastic leukemia. (2013)
- An Inv(16)(p13.3q24.3)-encoded CBFA2T3-GLIS2 fusion protein defines an aggressive subtype of pediatric acute megakaryoblastic leukemia. (2012)
- Molecular genetics of B-precursor acute lymphoblastic leukemia. (2012)
- Control-FREEC: a tool for assessing copy number and allelic content using next-generation sequencing data. (2012)
- The Pediatric Cancer Genome Project. (2012)
- VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. (2012)
Merged raw entities (11)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| poor outcome | phenotype | 26 | 39 |
| clinical outcomes | phenotype | 25 | 30 |
| outcome | phenotype | 24 | 39 |
| clinical outcome | phenotype | 20 | 23 |
| poor outcomes | phenotype | 12 | 13 |
| treatment outcome | phenotype | 12 | 15 |
| treatment outcomes | phenotype | 4 | 4 |
| better outcome | phenotype | 3 | 4 |
| poor treatment outcome | phenotype | 3 | 3 |
| o | phenotype | 1 | 1 |
| children's poor outcomes | phenotype | — | — |